Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2021 Filed Jun 21, 2021 20:29 UTC |
Jimenez Freddy A.SVP & General Counsel
|
GrantIncentive Stock Option (right to buy) · Derivative | 73,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006912 · edgar.xml · derivative · entry 1 Jimenez Freddy A. · CIK 0001838114 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,000 Underlying: Common Stock · 73,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:29 UTC |
Young Diane C.SVP, Chief Medical Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 72,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006911 · edgar.xml · derivative · entry 1 Young Diane C. · CIK 0001648010 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:29 UTC |
Heath-Chiozzi MargoSVP of Regulatory Affairs
|
GrantIncentive Stock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006910 · edgar.xml · derivative · entry 1 Heath-Chiozzi Margo · CIK 0001718112 · SVP of Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:28 UTC |
Wright Richard M.Sr. VP & CCO
|
GrantIncentive Stock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006909 · edgar.xml · derivative · entry 1 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:28 UTC |
Cavanaugh SarahSVP of Corp Affairs & Admin.
|
GrantIncentive Stock Option (right to buy) · Derivative | 56,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006908 · edgar.xml · derivative · entry 1 Cavanaugh Sarah · CIK 0001709113 · SVP of Corp Affairs & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Common Stock · 56,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:27 UTC |
PEPIN RONALDSr. VP & CBO
|
GrantIncentive Stock Option (right to buy) · Derivative | 15,500 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006907 · edgar.xml · derivative · entry 1 PEPIN RONALD · CIK 0001214504 · Sr. VP & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500 Underlying: Common Stock · 15,500 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:27 UTC |
Crowley ElizabethSr. VP &CPDO
|
GrantIncentive Stock Option (right to buy) · Derivative | 58,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006906 · edgar.xml · derivative · entry 1 Crowley Elizabeth · CIK 0001681854 · Sr. VP &CPDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Common Stock · 58,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:26 UTC |
Martin Samuel BatesSVP and CFO
|
GrantIncentive Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006905 · edgar.xml · derivative · entry 1 Martin Samuel Bates · CIK 0001709024 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:26 UTC |
KELER TIBORExecutive VP & CSO
|
GrantIncentive Stock Option (right to buy) · Derivative | 91,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006904 · edgar.xml · derivative · entry 1 KELER TIBOR · CIK 0001429931 · Executive VP & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,000 Underlying: Common Stock · 91,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:26 UTC |
Marucci Anthony SDirector · President & CEO
|
GrantIncentive Stock Option (right to buy) · Derivative | 224,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006903 · edgar.xml · derivative · entry 1 Marucci Anthony S · CIK 0001429933 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,000 Underlying: Common Stock · 224,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:20 UTC |
Brownlie Keith LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006892 · edgar.xml · derivative · entry 1 Brownlie Keith L · CIK 0001518575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. F1 · date: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:20 UTC |
PENNER HARRY JRDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006890 · edgar.xml · derivative · entry 1 PENNER HARRY JR · CIK 0001131148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:19 UTC |
Shoos Karen L.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006889 · edgar.xml · derivative · entry 1 Shoos Karen L. · CIK 0001255681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:19 UTC |
MARINO JAMES JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006887 · edgar.xml · derivative · entry 1 MARINO JAMES J · CIK 0001198578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:19 UTC |
CONRAD HERBERT JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006888 · edgar.xml · derivative · entry 1 CONRAD HERBERT J · CIK 0001218815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-06-17 F1 · security: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:30 UTC |
Wright Richard M.Sr. VP & CCO
|
Exercise / conversionIncentive Stock Option · Derivative | 9,375 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001179110-20-011996 · edgar.xml · derivative · entry 6 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,625 Underlying: Common Stock · 9,375 shares Expires 2029-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:30 UTC |
Wright Richard M.Sr. VP & CCO
|
Exercise / conversionIncentive Stock Option · Derivative | 11,457 | $0.00 Strike: $9.02 | $0.00 |
DisclosureSEC source: 0001179110-20-011996 · edgar.xml · derivative · entry 5 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,876 Underlying: Common Stock · 11,457 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but was adjusted to reflect the reverse stock split that occurred on February 8, 2019. F3 · derivative.exercise_date: 25% vested on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. F2 · balance_after: This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but was adjusted to reflect the reverse stock split that occurred on February 8, 2019. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:30 UTC |
Wright Richard M.Sr. VP & CCO
|
SaleCommon Stock | 9,375 | $18.61 | $174,435.94 |
DisclosureSEC source: 0001179110-20-011996 · edgar.xml · nonDerivative · entry 4 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208 F1 · balance_after: On February 8, 2019, the Company implemented a one-for-fifteen reverse stock split of the Company's issued and outstanding common stock, resulting in the reporting person's ownership of 208 shares of the Company's common stock. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:30 UTC |
Wright Richard M.Sr. VP & CCO
|
Exercise / conversionCommon Stock | 9,375 | $2.78 | $26,062.50 |
DisclosureSEC source: 0001179110-20-011996 · edgar.xml · nonDerivative · entry 3 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On February 8, 2019, the Company implemented a one-for-fifteen reverse stock split of the Company's issued and outstanding common stock, resulting in the reporting person's ownership of 208 shares of the Company's common stock. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:30 UTC |
Wright Richard M.Sr. VP & CCO
|
SaleCommon Stock | 11,457 | $18.61 | $213,174.67 |
DisclosureSEC source: 0001179110-20-011996 · edgar.xml · nonDerivative · entry 2 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208 F1 · balance_after: On February 8, 2019, the Company implemented a one-for-fifteen reverse stock split of the Company's issued and outstanding common stock, resulting in the reporting person's ownership of 208 shares of the Company's common stock. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:30 UTC |
Wright Richard M.Sr. VP & CCO
|
Exercise / conversionCommon Stock | 11,457 | $9.02 | $103,302.04 |
DisclosureSEC source: 0001179110-20-011996 · edgar.xml · nonDerivative · entry 1 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but was adjusted to reflect the reverse stock split that occurred on February 8, 2019. F1 · balance_after: On February 8, 2019, the Company implemented a one-for-fifteen reverse stock split of the Company's issued and outstanding common stock, resulting in the reporting person's ownership of 208 shares of the Company's common stock. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:07 UTC |
Martin Samuel BatesSVP and CFO
|
GrantIncentive Stock Option (right to buy) · Derivative | 105,600 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007598 · edgar.xml · derivative · entry 1 Martin Samuel Bates · CIK 0001709024 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,600 Underlying: Common Stock · 105,600 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:06 UTC |
Cavanaugh SarahSVP of Corp Affairs & Admin.
|
GrantIncentive Stock Option (right to buy) · Derivative | 84,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007596 · edgar.xml · derivative · entry 1 Cavanaugh Sarah · CIK 0001709113 · SVP of Corp Affairs & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:07 UTC |
Heath-Chiozzi MargoSVP of Regulatory Affairs
|
GrantIncentive Stock Option (right to buy) · Derivative | 84,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007597 · edgar.xml · derivative · entry 1 Heath-Chiozzi Margo · CIK 0001718112 · SVP of Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:06 UTC |
Crowley ElizabethSr. VP &CPDO
|
GrantIncentive Stock Option (right to buy) · Derivative | 84,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007595 · edgar.xml · derivative · entry 1 Crowley Elizabeth · CIK 0001681854 · Sr. VP &CPDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:06 UTC |
PEPIN RONALDSr. VP & CBO
|
GrantIncentive Stock Option (right to buy) · Derivative | 14,400 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007594 · edgar.xml · derivative · entry 1 PEPIN RONALD · CIK 0001214504 · Sr. VP & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,400 Underlying: Common Stock · 14,400 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:05 UTC |
Wright Richard M.Sr. VP & CCO
|
GrantIncentive Stock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007593 · edgar.xml · derivative · entry 1 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:05 UTC |
Young Diane C.SVP, Chief Medical Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 72,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007592 · edgar.xml · derivative · entry 1 Young Diane C. · CIK 0001648010 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:04 UTC |
Marucci Anthony SDirector · President & CEO
|
GrantIncentive Stock Option (right to buy) · Derivative | 245,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007590 · edgar.xml · derivative · entry 1 Marucci Anthony S · CIK 0001429933 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,000 Underlying: Common Stock · 245,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:05 UTC |
KELER TIBORExecutive VP & CSO
|
GrantIncentive Stock Option (right to buy) · Derivative | 108,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007591 · edgar.xml · derivative · entry 1 KELER TIBOR · CIK 0001429931 · Executive VP & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,000 Underlying: Common Stock · 108,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:04 UTC |
Brownlie Keith LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007589 · edgar.xml · derivative · entry 1 Brownlie Keith L · CIK 0001518575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:03 UTC |
CONRAD HERBERT JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007587 · edgar.xml · derivative · entry 1 CONRAD HERBERT J · CIK 0001218815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:03 UTC |
MARINO JAMES JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007588 · edgar.xml · derivative · entry 1 MARINO JAMES J · CIK 0001198578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:03 UTC |
Shoos Karen L.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007586 · edgar.xml · derivative · entry 1 Shoos Karen L. · CIK 0001255681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 12:02 UTC |
PENNER HARRY JRDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001179110-20-007585 · edgar.xml · derivative · entry 1 PENNER HARRY JR · CIK 0001131148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2030-06-18 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 11:55 UTC |
Young Diane C.SVP, Chief Medical Officer
|
PurchaseCommon stock, par value $0.001 per share | 2,115 | $4.73 | $10,003.95 |
DisclosureSEC source: 0001179110-20-007242 · edgar.xml · nonDerivative · entry 1 Young Diane C. · CIK 0001648010 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,115 Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 11:54 UTC |
Cavanaugh SarahSVP of Corp Affairs & Admin.
|
PurchaseCommon Stock, par value $0.001 per share | 1,050 | $4.83 | $5,071.50 |
DisclosureSEC source: 0001179110-20-007218 · edgar.xml · nonDerivative · entry 1 Cavanaugh Sarah · CIK 0001709113 · SVP of Corp Affairs & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 11:55 UTC |
Heath-Chiozzi MargoSVP of Regulatory Affairs
|
PurchaseCommon Stock, par value $0.001 per share | 1,000 | $3.01 | $3,005.00 |
DisclosureSEC source: 0001179110-20-007167 · edgar.xml · nonDerivative · entry 1 Heath-Chiozzi Margo · CIK 0001718112 · SVP of Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 11:55 UTC |
Martin Samuel BatesSVP and CFO
|
PurchaseCommon Stock, par value $0.001 per share | 9,750 | $3.05 | $29,737.50 |
DisclosureSEC source: 0001179110-20-007166 · edgar.xml · nonDerivative · entry 1 Martin Samuel Bates · CIK 0001709024 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,735 F1 · balance_after: Includes 985 shares of Common Stock acquired under the Company's 2004 Employee Stock Purchase Plan. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 11:54 UTC |
MARINO JAMES JDirector
|
PurchaseCommon Stock, par value $0.001 per share | 8,305 | $3.00 | $24,915.00 |
DisclosureSEC source: 0001179110-20-007165 · edgar.xml · nonDerivative · entry 1 MARINO JAMES J · CIK 0001198578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,704 Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 11:54 UTC |
Marucci Anthony SDirector · President & CEO
|
PurchaseCommon Stock, par value $0.001 per share | 15,000 | $3.06 | $45,900.00 |
DisclosureSEC source: 0001179110-20-007163 · edgar.xml · nonDerivative · entry 1 Marucci Anthony S · CIK 0001429933 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,438 F1 · balance_after: Includes 1,103 shares of Common Stock acquired under the Company's 2004 Employee Stock Purchase Plan. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 11:54 UTC |
KELER TIBORExecutive VP & CSO
|
PurchaseCommon Stock, par value $0.001 per share | 5,000 | $2.99 | $14,954.00 |
DisclosureSEC source: 0001179110-20-007164 · edgar.xml · nonDerivative · entry 1 KELER TIBOR · CIK 0001429931 · Executive VP & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,357 Read SEC document |
| July 08, 2019 Filed Jul 9, 2019 12:18 UTC |
Young Diane C.SVP, Chief Medical Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001179110-19-008540 · edgar.xml · derivative · entry 1 Young Diane C. · CIK 0001648010 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-07-08 F1 · security: Represents option granted by Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vests on July 8, 2020 and the remainder vests quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:29 UTC |
Wright Richard M.Sr. VP & CCO
|
GrantIncentive Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001179110-19-007978 · edgar.xml · derivative · entry 1 Wright Richard M. · CIK 0001646423 · Sr. VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-06-19 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:28 UTC |
Crowley ElizabethSr. VP &CPDO
|
GrantIncentive Stock Option (right to buy) · Derivative | 43,000 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001179110-19-007976 · edgar.xml · derivative · entry 1 Crowley Elizabeth · CIK 0001681854 · Sr. VP &CPDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 43,000 shares Expires 2029-06-19 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:27 UTC |
Marucci Anthony SDirector · President & CEO
|
GrantIncentive Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001179110-19-007972 · edgar.xml · derivative · entry 1 Marucci Anthony S · CIK 0001429933 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-06-19 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:29 UTC |
PEPIN RONALDSr. VP & CBO
|
GrantIncentive Stock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001179110-19-007979 · edgar.xml · derivative · entry 1 PEPIN RONALD · CIK 0001214504 · Sr. VP & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2029-06-19 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:28 UTC |
Heath-Chiozzi MargoSVP of Regulatory Affairs
|
GrantIncentive Stock Option (right to buy) · Derivative | 43,000 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001179110-19-007977 · edgar.xml · derivative · entry 1 Heath-Chiozzi Margo · CIK 0001718112 · SVP of Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 43,000 shares Expires 2029-06-19 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:28 UTC |
Cavanaugh SarahSVP of Corp Affairs & Admin.
|
GrantIncentive Stock Option (right to buy) · Derivative | 43,000 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001179110-19-007975 · edgar.xml · derivative · entry 1 Cavanaugh Sarah · CIK 0001709113 · SVP of Corp Affairs & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 43,000 shares Expires 2029-06-19 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:27 UTC |
Martin Samuel BatesSVP and CFO
|
GrantIncentive Stock Option (right to buy) · Derivative | 43,000 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001179110-19-007974 · edgar.xml · derivative · entry 1 Martin Samuel Bates · CIK 0001709024 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 43,000 shares Expires 2029-06-19 F1 · security: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. F2 · derivative.exercise_date: 25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.